Previous 10 | Next 10 |
--News Direct-- Vivos Therapeutics CEO Kirk Huntsman joined Steve Darling from Proactive to share news the company has signed a nationwide distribution agreement in the United States with Lincare, a prominent supplier of in-home respiratory therapy products and services catering to approx...
Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-moderate obstructive sleep apnea (“OSA”) and snoring in adults, has closed its previously announced priva...
LITTLETON, Colo., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS) , a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-mo...
2023-10-31 09:20:32 ET More on Vivos Therapeutics Vivos Therapeutics announces 1-for-25 reverse stock split Vivos Therapeutics, Lincare ink distribution deal Seeking Alpha’s Quant Rating on Vivos Therapeutics Historical earnings data for Vivos Therapeu...
LITTLETON, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-moderat...
2023-10-27 13:45:10 ET Gainers: Forbion European Acquisition Corp ( FRBN ) +103% . Spectaire Holdings ( SPEC ) +40% . Nerdwallet ( NRDS ) +38% . Integrated Media Technology Limited ( IMTE ) +34% . Envoy Medical ( COCH ) +25% . ...
2023-10-27 10:02:45 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector as earnings close in BofA reports 10th consecutive week of equity inflows For further detail...
2023-10-26 10:22:03 ET More on Vivos Therapeutics Vivos Therapeutics, Lincare ink distribution deal Vivos Therapeutics GAAP EPS of -$0.18 misses by $0.04, revenue of $3.4M misses by $0.72M Seeking Alpha’s Quant Rating on Vivos Therapeutics Historical e...
LITTLETON, Colo., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (ȁ...
2023-10-24 09:17:29 ET Medical technology firm Vivos Therapeutics ( NASDAQ: VVOS ) has entered into a U.S. nationwide distribution deal with in-home respiratory therapy products supplier, Lincare. Under the deal, Lincare will have a six-month exclusivity to distribute cert...
News, Short Squeeze, Breakout and More Instantly...
Vivos Therapeutics Inc. Company Name:
VVOS Stock Symbol:
NASDAQ Market:
Vivos Therapeutics Inc. Website:
LITTLETON, Colo., June 27, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company” (NASDAQ:VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments f...
Vivos Therapeutics (NASDAQ: VVOS) is a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders (including all severities of obstructive sleep apnea (“OSA”) i...
Alliance with Sleep Treatment Provider in Colorado Marks Critical Pivot in Vivos’ Marketing and Distribution Model Aimed at Enhancing Revenue Streams and Potential Profit Private Placement Investment Sponsored by Seneca Partners, Who Will Also Provide General Management Advisory ...